Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: An update on 100 patients

British Journal of Haematology

Volumn 105, Issue 3, 1999, Pages 786-794

  Fruehauf, Stefan ^a   Schmitt, Karin ^b   Veldwijk, Marlon R ^b   Topaly, Julian ^b   Benner, Axel ^c   Zeller, W Jens ^b   Ho, Anthony D ^a   Haas, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Res Prog Diagn and Exp Therapy   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CD34; Haemopoiesis; Mobilization; PBPC; Steady state

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; MITOXANTRONE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ARTICLE; BONE MARROW TOXICITY; CELL COUNT; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PREDICTION; PRIORITY JOURNAL;

ADULT; CELL COUNT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HODGKIN DISEASE; HUMANS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 0033067494     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01405.x     Document Type: Article

References (24)

1. Ali, S.M., Mierski, J., Gordon, R., Ehman, C., Bongiovanni, M. & Rybka, W. (1997) Low baseline peripheral blood (PB) CD34 does not predict outcome in donors mobilized by chemotherapy and G-CSF. Blood, 90, 210a.
2. Altman, D.G. (1991) Practical Statistics for Medical Research, p. 315. Chapman & Hall, London.
3. Bender, J.G., Unverzagt, K.I., Walker, D.E., Lee, W., Van Epps, D., Smith, D.H., Stewart, C.C. & To, L.B. (1991) Identification and comparison CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood, 77, 2591-2596.
4. (+) cells in blood. Blood, 88, 402a.
5. Desikan, K.R., Jagannath, S., Siegel, D., Nelson, J., Bracy, D., Barlogie, B. & Tricot, G. (1998) Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma. Leukemia and Lymphoma, 28, 501-508.
6. Drake, M., Ranaghan, L., Morris, T.C., Nolan, L., Desai, Z.R., Irvine, A.E., Jordan, A., Magill, K. & Price, S. (1997) Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. British Journal of Haematology, 98, 745-749.
7. Efron, B. & Tibshirani, R.J. (1993) An Introduction to the Bootstrap. Chapman & Hall, New York.
8. Fruehauf, S., Haas, R., Conradt, C., Murea, S., Witt, B., Möhle, R. & Hunstein, W. (1995) Peripheral blood progenitor cells (PBPC) counts during steady-state hemopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood, 85, 2619-2626.
9. + cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy. Stem Cells, 16, 271-279.
10. Glück, S., Ross, A.A., Layton, T.J., Ostrander, A.B., Goldstein, L.C., Porter, K. & Ho, A.D. (1997) Decrease in tumor cell contamination and progenitor cell yield in leukaphereses products after consecutive cycles of chemotherapy for breast cancer treatment. Biology of Blood and Marrow Transplantation, 3, 316-323.
11. 2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplantation, 17, 691-697.
12. Goldschmidt, H., Hegenbart, U., Wallmeier, M., Hohaus, S. & Haas, R. (1997) Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimuluting factor in patients with multiple myeloma. British Journal of Haematology, 98, 736-744.
13. Haas, R., Möhle, R., Fruehauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994a) Patient characteristics associated with successful mobilising and auto-grafting of peripheral blood progenitor cells (PBPC) in malignant lymphoma. Blood, 83, 3787-3794.
14. Haas, R., Moos, M., Karcher, A., Möhle, R., Witt, B., Goldschmidt, H., Fruehauf, S., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994b) Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685-1692.
15. - cells and platelet counts in autologous patients predict the yield of PBSC collections. Blood, 90, 211a.
16. Husson, B., Ravoct, C., Dehon, M., Wallef, G., Hougardy, N. & Delannoy, A. (1996) Predictive value of the steady-state peripheral blood progenitor cell (PBPC) counts for the yield of PBPC collected by leukaphereses after mobilization by granulocyte colony-stimulating factor (G-CSF) alone or chemotherapy and G-CSF. Blood, 87, 3526-3528.
17. McQuaker, I.G., Haynes, A.P., Stainer, C., Anderson, S. & Russell, N.H. (1997) Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. British Journal of Haematology, 98, 228-233.
18. + progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Experimental Hematology, 23, 1535-1542.
19. Müller-Sieburg, C.E. (1997) The allelic forms of the stem cell frequency genes (Scfr) predict the mobilization capacity of stem cells but not the cycling status of stem cells. Blood, 90, 259a.
20. Murea, S., Goldschmidt, H., Hahn, U., Pforsich, M., Moos, M. & Haas, R. (1996) Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. Journal of Clinical Apheresis, 11, 185-194.
21. Passos-Coelho, J.L., Braine, H.G., Davis, J.M., Huelskamp, A.M., Schepers, K.G., Ohly, K., Clarke, B., Wright, S.K., Noga, S.J., Davidson, N.E. & Kennedy, M.J. (1995) Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukaphereses after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. Journal of Clinical Oncology, 13, 705-714.
22. Prince, H.M., Imrie, K., Sutherland, D.R., Keating, A., Meharchand, J., Crump, R.M., Girouard, C., Trip, K. & Stewart, A.K. (1996) Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections. British Journal of Haematology, 93, 142-145.
23. To, L.B., Haylock, D.N., Simmons, P.J. & Juttner, C.A. (1997) The biology and clinical uses of blood stem cells. Blood, 89, 2233-2258.
24. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, 588-596.